InvestorsHub Logo
Followers 27
Posts 4023
Boards Moderated 0
Alias Born 01/11/2012

Re: None

Tuesday, 10/02/2018 1:50:21 PM

Tuesday, October 02, 2018 1:50:21 PM

Post# of 40492
Inovio Pharmaceuticals (NASDAQ:INO) is now covered by analysts at Stifel Nicolaus ( ). They set a "buy" rating and a $8.00 price target on the stock. 30.9% upside from the current price of $6.11.




What do these analysts know???
One has an $8 price target the other has a $13 price target. That is quite a lot of difference for a $5-$6 stock. And usually none of them ever get met.

Come on $9. I want break-even to get out since holding over 2 years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News